MultiCell Technologies Inc (MCET)

[redsox17]

This is huge MCT-485 has demonstrated in in vitro models the ability to kill transformed liver cancer cells while not harming normal, non-transformed liver cells. "MCT-485 addresses the need to directly target liver cancer cells and not normal liver cells", said W. Gerald Newmin, Chairman and Chief Executive Officer. MCT-485 is currently being evaluated in animal models of hepatocellular carcinoma. MultiCell also plans to study MCT-485 in relevant in vitro and animal models for other major cancers.

http://finance.yahoo.com/news/multicell-technologies-files-u-international-123900101.html